NYSE - Delayed Quote USD

Enfusion, Inc. (ENFN)

Compare
8.76 -0.05 (-0.57%)
At close: October 18 at 4:00 PM EDT
8.76 0.00 (0.00%)
After hours: October 18 at 5:30 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 49.45M
Earnings 1.83M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

8.00 Low
9.31 Average
8.76 Current
10.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 0.060.070.220.3
Low Estimate 0.040.050.170.21
High Estimate 0.070.080.260.36
Year Ago EPS 0.040.040.130.22

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 7799
Avg. Estimate 52.17M55.26M204.8M241.78M
Low Estimate 50.98M53.41M202.22M233.9M
High Estimate 53M56.99M207.5M247.6M
Year Ago Sales --46.49M174.53M204.8M
Sales Growth (year/est) --18.90%17.30%18.10%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 0.050.050.040.06
EPS Actual 0.040.040.060.05
Difference -0.01-0.010.02-0.01
Surprise % -20.00%-20.00%50.00%-16.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.060.070.220.3
7 Days Ago 0.060.070.220.3
30 Days Ago 0.060.070.220.3
60 Days Ago 0.060.070.220.3
90 Days Ago 0.060.070.240.34

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD ENFNIndustrySectorS&P 500
Current Qtr. 50.00%----3.70%
Next Qtr. 75.00%----7.90%
Current Year 69.20%----2.50%
Next Year 36.40%----13.10%
Next 5 Years (per annum) 85.70%----11.88%
Past 5 Years (per annum) 29.04%------

Upgrades & Downgrades

Maintains B of A Securities: Underperform to Underperform 3/13/2024
Downgrade Goldman Sachs: Neutral to Sell 2/28/2024
Downgrade JP Morgan: Neutral to Underweight 1/30/2024
Maintains Piper Sandler: Neutral to Neutral 12/20/2023
Initiated UBS: Neutral 11/7/2023
Maintains Goldman Sachs: Neutral to Neutral 8/9/2023

Related Tickers